Results showed that chemotherapy appeared to be administered more often among patients with adenocarcinoma or adenosquamous histology than squamous cell carcinoma (RR = 1.26; 95% CI, 1.1-1.44).

Median age was 58 years, 71% of patients were men, 84% had clear cell histology, 53% were at intermediate risk of recurrence, and 47% were at high risk of recurrence. We observed no differences in DFS ...

Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe ...

Small cell undifferentiated (SCU) histology in hepatoblastoma (HB) tumors has historically been associated with a poor prognosis. Tumors from patients enrolled on Children's Oncology Group (COG) study ...

Medullary cell, collecting duct, and unspecified RCC were significantly associated with 82%, 65%, and 71% increased risks of dying within 5 years, respectively.

This function controls cell adhesion, migration and cell survival, a process called intermediate cell adhesion. She and her team discovered the role of thrombospondin-1 (TSP-1) as an activator of ...

It supplies its host cells with metabolites and so-called co-factors, which have e.g. a catalytic function in enzymes. "It is noteworthy that each host cell has just one of these endosymbionts ...

Squamous cell histology group: Median OS in the chemotherapy-plus-cemiplimab group was 22.3 months; Median OS in the chemotherapy-plus-placebo group was 13.8 months (HR, 0.61; 95% CI, 0.42-0.87) ...

In SWOG S1609, among 19 patients with ovarian clear cell carcinoma who were treated with nivolumab and ipilimumab for up to 2 years, followed by nivolumab alone, the overall response rate was 21%.